Literature Collection

Collection Insights

10K+

References

9K+

Articles

1400+

Grey Literature

4500+

Opioids & SU

The Literature Collection contains over 10,000 references for published and grey literature on the integration of behavioral health and primary care. Learn More

Use the Search feature below to find references for your terms across the entire Literature Collection, or limit your searches by Authors, Keywords, or Titles and by Year, Type, or Topic. View your search results as displayed, or use the options to: Show more references per page; Sort references by Title or Date; and Refine your search criteria. Expand an individual reference to View Details. Full-text access to the literature may be available through a link to PubMed, a DOI, or a URL. References may also be exported for use in bibliographic software (e.g., EndNote, RefWorks, Zotero).

Year
Sort by
Order
Show
10858 Results
5942
Medication-Assisted Treatment for Opioid Addiction: Facts for Families and Friends
Type: Government Report
Authors: Center for Substance Abuse Treatment
Year: 2014
Publication Place: Rockville, MD
Topic(s):
Grey Literature See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

5943
Medication-assisted treatment for opioid addiction: methadone and buprenorphine
Type: Journal Article
Authors: A. J. Saxon, Y. I. Hser, G. Woody, W. Ling
Year: 2013
Abstract: Among agents for treatment of opioid addiction, methadone is a full mu-opioid receptor agonist, whereas buprenorphine is a partial agonist. Both are long-acting. Buprenorphine has a superior safety profile. Methadone is formulated for oral administration and buprenorphine for sublingual administration. A subdermal buprenorphine implant with a 6-month duration of action is being considered for approval by the U.S. Food and Drug Administration. Both medications reduce mortality rates and improve other outcomes. Data from a recent randomized controlled comparison of both medications (N = 1269) show better treatment retention with methadone but reduced illicit opioid use early in treatment with buprenorphine. Human immunodeficiency virus (HIV) risk behaviors were measured using the Risk Behavior Survey at baseline, 12 weeks, and 24 weeks for study completers. In the 30 days prior to treatment entry, 14.4% of the completers randomized to treatment with buprenorphine (n = 340) and 14.1% of the completers randomized to methadone treatment (n = 391) shared needles. The percent sharing needles decreased to 2.4% for buprenorphine and 4.8 for methadone in the 30 days prior to Week 24 (p < 0.0001). In the 30 days prior to treatment entry, 6.8% of the completers randomized to buprenorphine and 8.2% of the completers randomized to methadone had multiple sexual partners, with only 5.2% and 5.1%, respectively, reporting multiple partners at Week 24 (p < 0.04).
Topic(s):
Opioids & Substance Use See topic collection
5945
Medication-Assisted Treatment for Opioid Use Disorder in a Rural Family Medicine Practice
Type: Journal Article
Authors: M. Deyo-Svendsen, Cabrera Svendsen, J. Walker, A. Hodges, R. Oldfather, M. P. Mansukhani
Year: 2020
Abstract:

Opioid use disorder (OUD) is a cause of significant morbidity and mortality in the United States. Although efforts are being made to limit access to prescription opioids, the use of heroin and synthetic opioids as well as death due to opioid overdose has increased. Medication-assisted treatment (MAT) is the pairing of psychosocial intervention with a Food and Drug Administration (FDA)-approved medication (methadone, buprenorphine plus naltrexone) to treat OUD. MAT has resulted in reductions in overdose deaths, criminal activity, and infectious disease transmission. Access to MAT in rural areas is limited by shortages of addiction medicine-trained providers, lack of access to comprehensive addiction programs, transportation, and cost-related issues. Rural physicians express concern about lack of mentorship and drug diversion as reasons to avoid MAT. The prescribing of MAT with buprenorphine requires a Drug Enforcement Agency (DEA) waiver that can easily be obtained by Family Medicine providers. MAT can be incorporated into the outpatient practice, where patient follow-up rates and number needed to treat to effect change are similar to that of other chronic medical conditions. We describe a case of opioid overdose and a suggested protocol for the induction of MAT with buprenorphine/naloxone (Suboxone) for OUD in a rural family medicine outpatient practice. Treatment access is facilitated by utilizing the protocol, allowing office staff work to the extent allowed by their licensure, promoting teamwork and minimizing physician time commitment. We conclude that improved access to MAT can be accomplished in a rural family medicine outpatient clinic by staff that support and mentor one another through use of a MAT protocol.

Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
5946
Medication-Assisted Treatment for Opioid Use Disorder in Pregnancy: Practical Applications and Clinical Impact
Type: Journal Article
Authors: L. Zhao, C. Cheng, L. Bouchard
Year: 2020
Publication Place: United States
Abstract:

IMPORTANCE: Opioid use disorder is increasingly common in the United States and affects many pregnancies. Given the rise in pregnancies complicated by opioid use, providers should understand the diagnosis and management of opioid use disorder in pregnancy. OBJECTIVE: This article focuses on screening for opioid misuse, selecting appropriate treatment for patients, initiating medication-assisted treatment in the inpatient setting, and providing appropriate peripartum care. EVIDENCE ACQUISITION: A PubMed search was undertaken using the following search terms: "opioid use disorder", "pregnancy," "medication assisted treatment," "buprenorphine," "methadone," "heroin," "addiction," "neonatal abstinence syndrome," and "detoxification." The search was limited to the English language publications, with most being published after 2000. RESULTS: All women should be screened for opioid use disorder during pregnancy. Opioid use has profound effects on the mother and infant. Medication-assisted treatment is the standard of care for pregnant women with opioid use disorder. Patients will require a multidisciplinary approach to management in the intrapartum and postpartum period. CONCLUSIONS: Opioid use disorder is a common, chronic condition with significant implications during pregnancy. Recognition and appropriate treatment of this disorder can optimize maternal and fetal outcomes. CONCLUSIONS: Obstetricians are increasingly being challenged to manage pregnancies complicated by opioid use disorder and should be proficient in providing safe and effective care.

Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
5947
Medication-Assisted Treatment for Opioid Use Disorder in the Justice System
Type: Government Report
Authors: Inc. American Association for the Treatment of Opioid Dependence
Year: 2017
Publication Place: New York, NY
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
,
Grey Literature See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

5948
Medication-Assisted Treatment for Opioid Use Disorder: Proceedings of a Workshop--in Brief
Type: Report
Authors: National Academies of Sciences, Engineering, and Medicine
Year: 2018
Topic(s):
Grey Literature See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

5949
Medication-assisted treatment for opioid-dependent individuals [Dissertation]
Type: Web Resource
Authors: Sharmain Jones
Year: 2013
Abstract: This project reviewed the literature on methadone and buprenorphine treatment for opioid addiction. Methadone and buprenorphine have been widely studied and researched and the findings consistently suggested that methadone and buprenorphine are medically safe and effective treatment for opioid addiction. Methadone and buprenorphine reduce and/or eliminate the use of heroin, illicit opiates, reduce death rates, and criminality associated with heroin use, and allow individuals to improve their health and social productivity. Study after study continued to prove the efficacy of methadone and buprenorphine for opioid addiction. Medication assisted treatment such as methadone and buprenorphine have a role in clinical social work practice and should be viewed by providers as another treatment option for individuals struggling with opioid addiction. The potential implication for social work clinical practice is that medication-assisted treatment is a viable treatment option for individuals with an opioid addiction.
Topic(s):
Opioids & Substance Use See topic collection
,
Education & Workforce See topic collection
,
Grey Literature See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

5950
Medication-assisted treatment for pregnant women: A systematic review of the evidence and implications for social work practice
Type: Journal Article
Authors: Amber M. Holbrook, Viba H. Nguyen
Year: 2015
Topic(s):
Opioids & Substance Use See topic collection
,
Education & Workforce See topic collection
5951
Medication-Assisted Treatment for Pregnant Women: An Interdisciplinary Group Based Model
Type: Journal Article
Authors: Laura R. Lander, Patrick Marshalek, Carl R. Sullivan
Year: 2016
Publication Place: Philadelphia
Topic(s):
Opioids & Substance Use See topic collection
5953
Medication-assisted treatment improves child permanency outcomes for opioid-using families in the child welfare system
Type: Journal Article
Authors: Martin T. Hall, Jordan Wilfong, Ruth A. Huebner, Lynn Posze, Tina Willauer
Year: 2016
Topic(s):
Opioids & Substance Use See topic collection
5954
Medication-Assisted Treatment Improves Outcomes for Patients with Opioid Use Disorder
Type: Report
Authors: The Pew Charitable Trusts
Year: 2016
Publication Place: Washington, DC
Topic(s):
Grey Literature See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

5955
Medication-Assisted Treatment in Drug Courts: Recommended Strategies
Type: Government Report
Authors: Sally Friedman, Kate Wagner-Goldstein
Year: 2016
Publication Place: New York, NY
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Policy See topic collection
,
Grey Literature See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

5956
Medication-Assisted Treatment Models of Care for Opioid Use Disorder in Primary Care Settings. Technical Brief No. 28
Type: Government Report
Authors: R. Chou, PT Korthuis, M. Weimer, C. Bougatsos, I. Blazina, B. Zakher, S. Grusing, B. Devine, D. McCarty
Year: 2016
Publication Place: Rockville, MD
Topic(s):
Grey Literature See topic collection
,
Education & Workforce See topic collection
,
Financing & Sustainability See topic collection
,
Healthcare Policy See topic collection
,
HIT & Telehealth See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

5957
Medication-assisted treatment of opiate dependence is gaining favor
Type: Journal Article
Authors: J. M. Jerry, G. B. Collins
Year: 2013
Publication Place: United States
Abstract: People addicted to opiates are more likely to avoid returning to these drugs if they participate in a program that includes taking maintenance doses of methadone or buprenorphine than with an abstinence program. Although medical opinion has long been divided on the issue of abstinence vs medication-assisted treatment, the latter seems to be gaining respect as an evidence-based approach.
Topic(s):
Opioids & Substance Use See topic collection
5958
Medication-Assisted Treatment of Opioid Dependence: A Review of the Evidence
Type: Report
Authors: Kate A. Dolan, Zahra Alam Mehrjerdi
Year: 2015
Topic(s):
Grey Literature See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

5959
Medication-Assisted Treatment of Opioid Use Disorder in Adolescents and Young Adults
Type: Journal Article
Authors: C. B. Cottrill, S. C. Matson
Year: 2014
Publication Place: United States
Topic(s):
Opioids & Substance Use See topic collection
5960
Medication-Assisted Treatment of Opioid Use Disorder Pocket Guide
Type: Government Report
Authors: Substance Abuse and Mental Health Services Administration
Year: 2016
Publication Place: Rockville, MD
Topic(s):
Grey Literature See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.